Amouyal Philippe
SEC CIK 1376854 · EDGAR
BoughtSold
Most active insiders at CAVA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Artal Participations S.a r.l. | Dir | — | $270.90M |
| 2 | Costanza Kelly | CHRO | — | $5.09M |
| 3 | Schulman Brett | CEO, Pres, Dir | $7,347 | $4.71M |
| 4 | Bertram Kenneth Robert | CLO, Sec | — | $1.75M |
| 5 | Xenohristos Theodoros | Chief Concept Off, Dir | — | $1.14M |
| 6 | Phillips Adam David | CAO | — | $1.11M |
| 7 | Thompson Douglas W. | Chief Ops Off | $944.9K | — |
| 8 | KOCHEVAR KAREN | Dir | — | $900.0K |
| 9 | Tolivar Tricia K. | CFO | — | $742.3K |
| 10 | KADOW JOSEPH JOHN | CLO, Sec | $199.0K | — |
| 14 | Amouyal Philippe | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-24 16:01 | 2026-06-22 | CAVA | CAVA GROUP, INC. | Amouyal Philippe | Dir | A - Grant | $0.00 | +1,881 | 20.0K | +10% | $0 | |
| D | 2026-06-04 16:10 | 2026-06-03 | LXRX | LEXICON PHARMACEUTICALS, INC. | Amouyal Philippe | Dir | M - OptEx | $0.00 | +89.3K | 374.5K | +31% | $0 |
| 2025-06-24 | 2025-06-20 | CAVA | CAVA GROUP, INC. | Amouyal Philippe | Dir | A - Grant | $0.00 | +1,767 | 18.1K | +11% | $0 | |
| D | 2025-05-13 | 2025-05-13 | LXRX | LEXICON PHARMACEUTICALS, INC. | Amouyal Philippe | Dir | M - OptEx | $0.00 | +36.8K | 285.2K | +15% | $0 |
| 2024-06-24 | 2024-06-20 | CAVA | CAVA GROUP, INC. | Amouyal Philippe | Dir | A - Grant | $0.00 | +1,307 | 16.3K | +9% | $0 | |
| D | 2024-04-29 | 2024-04-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Amouyal Philippe | Dir | M - OptEx | $0.00 | +8,032 | 248.4K | +3% | $0 |
| 2023-11-21 | 2023-11-17 | CAVA | CAVA GROUP, INC. | Amouyal Philippe | Dir | P - Purchase | $33.18 | +10.0K | 15.0K | +200% | +$331.8K | |
| 2023-11-14 | 2023-11-13 | LXRX | LEXICON PHARMACEUTICALS, INC. | Amouyal Philippe | Dir | P - Purchase | $1.01 | +200.0K | 240.3K | +496% | +$202.0K | |
| 2023-06-22 | 2023-06-20 | CAVA | CAVA GROUP, INC. | Amouyal Philippe | Dir | A - Grant | $0.00 | +5,000 | 5,000 | New | $0 | |
| D | 2023-05-22 | 2023-05-21 | LXRX | LEXICON PHARMACEUTICALS, INC. | Amouyal Philippe | Dir | M - OptEx | $0.00 | +9,302 | 40.3K | +30% | $0 |
| D | 2022-05-02 | 2022-04-30 | LXRX | LEXICON PHARMACEUTICALS, INC. | Amouyal Philippe | Dir | M - OptEx | $0.00 | +4,024 | 31.0K | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations